Outstanding Achievements for Global Well-Being and Our Shared Future

TAIPEI, Sept. 18, 2026 /PRNewswire/ -- The 2026 Tang Prize Award Ceremony brought together all six laureates in Taipei on September 18, with five receiving their awards in person and Biopharmaceutical Science laureate Dr. Steven A. Rosenberg taking part remotely. The laureates drew on decades of research, scholarship, and practice to address some of the most pressing challenges facing humanity and share their hopes for the future.

This year marked the first Tang Prize Award Ceremony since the passing of Tang Prize Founder Dr. Samuel Yen-Liang Yin, and a commemorative video was shown in his honor. Dr. Chung-Yao Yin, Chairman of the Tang Prize Foundation, said the framework and spirit established by his father will continue to be carried forward, and that the ceremony represents a continuation of the vision on which the Tang Prize was founded. Academician Chi-Huey Wong, President of the Tang Prize Selection Committee, said the selection committees for all four prize categories have consistently upheld objective, impartial, and professional standards in selecting laureates.

Professor Susan Solomon, the 2026 Tang Prize Laureate in Sustainable Development, noted that today's global environmental challenges may seem just as intractable as ozone depletion once did, but a combination of "science, public engagement, industry participation, and wise policy" enabled humanity to overcome that crisis. She expressed hope that humanity will once again succeed in "the moonshot of safeguarding our environment instead of destroying it."

Among the 2026 Tang Prize Laureates in Biopharmaceutical Science, Dr. Steven A. Rosenberg recalled that four decades ago, his team's work showed that tumor-infiltrating lymphocytes (TILs) derived from patients' tumors could mediate cancer regression, demonstrating that a patient's own lymphocytes could serve as a "living drug" against cancer. The work later led to therapeutic strategies using T cell receptors (TCRs) and chimeric antigen receptors (CARs). Rosenberg called it "a proud example of academic research" that led to lifesaving cancer treatments now available worldwide.

Dr. Michel Sadelain recalled that the idea of targeting CD19 with CAR T cells in the 1990s was rejected by most in academia and industry. He said the only way to advance the concept was to "do it yourself." His team treated its first patient in 2007, and the first CD19-targeted CAR therapies were approved by the U.S. Food and Drug Administration in 2017. Sadelain expressed particular gratitude to "the brave ones who risked their careers when this work was labelled 'science fiction.'"

Dr. Carl H. June said that for patients in the early clinical trials, the question was not whether CAR T-cell therapy was an elegant scientific idea, but whether it could give them more time: "Time with a spouse. Time to see a child grow up. For a child, time simply to grow up." He said patients and their families are "at the heart of this award" because they trusted the research team amid profound uncertainty. He added that whether a treatment reaches the people who need it must be part of how success is measured.

Professor Ge Zhaoguang, the 2026 Tang Prize Laureate in Sinology, noted that Sinology has become a global field of scholarship. Perspectives from different countries and regions are like mirrors held at different angles, together revealing a China that is nuanced and multifaceted. In his view, "the synthesis of East and West, together with pluralism and openness," is the path toward a flourishing field of Sinology.

Professor Bruce Ackerman, the 2026 Tang Prize Laureate in Rule of Law, reflected on growing up in one of New York City's most impoverished neighborhoods in the 1950s. His experience in public schools shaped by John Dewey's philosophy of progressive education encouraged him to explore alternative paths and think independently. At Harvard, he was deeply influenced by John Rawls. To this day, he continues to collaborate with colleagues in academia to explore the underlying sources of the worldwide crisis threatening the future of the rule of law.

Note: Livestream: https://youtube.com/live/DYKirmt37DI?feature=share 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/2026-tang-prize-award-ceremony-honors-six-laureates-302883221.html

Die niederösterreichische Volkspartei hat mehr als drei Jahre vor der nächsten Landtagswahl zentrale Weichen gestellt und setzt dabei konsequent auf Kontinuität. Landeshauptfrau Johanna Mikl-Leitner wurde vom Landesparteivorstand einstimmig zur Spitzenkandidatin für den Urnengang Anfang Jänner 2028 nominiert. Damit vertraut die ÖVP erneut auf ihre langjährige Landeschefin, die den von ihr ausgerufenen „eigenständigen, niederösterreichischen Weg“ mit den Leitmotiven Leistung, Eigenverantwortung und Hausverstand fortführen will.

Flankiert wird Mikl-Leitner von einem weitgehend bekannten Spitzenteam. Zum siebenköpfigen Führungskreis zählen Landeshauptfrau-Stellvertreter Stephan Pernkopf, Landesrätin Christiane Teschl-Hofmeister, Landesrat Anton (Toni) Kasser, Landtagspräsident Karl Wilfing, Klubobmann Kurt Hackl sowie Landesgeschäftsführer Matthias Zauner. Der entsprechende Beschluss zur Landesliste fiel ebenfalls einstimmig. Innerparteilich soll das Signal innerer Geschlossenheit helfen, sich frühzeitig auf ein erwartbar knappes Duell mit der FPÖ einzustellen.

Bei der Wahlorganisation kehrt die Partei zu einem Modell zurück, das in den vergangenen Monaten intern intensiv diskutiert wurde: In den Regionalwahlkreisen entscheiden wieder Vorzugsstimmen über die Reihung der Kandidaten. Eine Besonderheit ist ein Bonus von fünf Prozent für amtierende Landtagsabgeordnete, berechnet auf Basis der im jeweiligen Wahlkreis abgegebenen ÖVP-Stimmen. Der Schritt verschafft etablierten Mandataren einen spürbaren Startvorteil gegenüber neuen Bewerbern und trägt zugleich der Mobilisierungsstärke einzelner Teilorganisationen wie dem Bauernbund Rechnung.

Politisch rückt die Landespartei neben der strategischen Wahlvorbereitung in den kommenden Monaten vor allem die Themen Wirtschaft, Arbeit, Gesundheit und Kinderbetreuung in den Vordergrund. Mit einer bereits eingerichteten Taskforce Wirtschaft sollen Genehmigungsverfahren beschleunigt und Verwaltungsabläufe im Land langfristig gestrafft werden. Der Gesundheitsplan 2040+ bleibt als groß angelegtes Reformprojekt im Zentrum der Regierungsarbeit. Im Hintergrund bleibt der Druck hoch: Bei der Landtagswahl 2023 war die ÖVP auf 39,93 Prozent zurückgefallen, die FPÖ hatte 24,19 Prozent erreicht; aktuelle Umfragen deuten auf einen weiter schrumpfenden Abstand hin und lassen für 2028 ein deutlich engeres Rennen erwarten, in dem neue Mehrheitskonstellationen möglich werden könnten.